Tenax Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | +0.0% | +0.0% | +0.0% | – | – | – | – | – | – | – | – | +580.3% | +28.8% | -30.4% | +0.0% | -82.9% | +0.0% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +1,258.4% | -90.3% | +153.3% | +0.0% | +0.0% | -92.5% | +94.8% | -28.1% | -33.8% | +1,090.0% | +7.0% | -5.0% | +4.0% | -93.3% | – | – | |
| – | – | – | -46.0% | +32.7% | +0.0% | – | – | – | – | – | – | – | – | -2,588.4% | – | -56.3% | +0.0% | -69.0% | -19.7% | -147.9% | – | – | – | – | – | – | – | – | – | |
| – | -50.1% | -56.6% | +12.0% | +0.0% | +249.2% | +67.9% | +9.1% | -10.9% | +0.1% | -5.7% | -37.5% | +24.9% | +216.5% | -9.8% | -8.2% | +21.7% | +0.0% | +122.3% | +0.0% | +427.6% | -90.0% | -64.9% | +180.1% | +31.4% | +451.4% | -78.6% | -40.0% | +293.6% | +157.1% | |
| – | +0.0% | -20.4% | -38.9% | -1.8% | +77.4% | +87.8% | -63.3% | +17.9% | +42.0% | -9.5% | -20.0% | +95.4% | +251.4% | +3.3% | +6.2% | +77.2% | +1.2% | -47.9% | +0.0% | -12.9% | -9.1% | -0.4% | -10.1% | +4.4% | +42.8% | -25.1% | -11.8% | +35.6% | +249.5% | |
| – | -19.1% | -47.3% | -3.4% | +114.8% | +0.0% | +73.8% | -36.9% | -0.3% | +18.4% | -7.7% | -28.5% | +65.5% | +248.1% | +4.5% | -19.5% | +95.4% | +0.0% | -11.4% | -7.0% | +280.7% | -82.5% | -25.1% | +24.1% | +14.0% | +235.6% | -66.2% | -25.5% | +136.8% | +189.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -93.3% | +0.0% | +1,170.7% | -100.0% | – | – | – | +1.4% | +115.2% | -95.7% | +10.7% | +4,220.3% | -70.2% | -100.0% | – | +0.0% | +66,117.8% | -100.0% | – | – | – | -41.7% | +368.2% | +439.4% | -4.0% | -100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +147.3% | -3,623.2% | – | -14.8% | -185.2% | – | – | – | – | – | – | – | -80.9% | +492.5% | -91.9% | +633.9% | -100.0% | – | -65.1% | -3,274.0% | – | – | – | – | +1,192.3% | -101.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.